Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | ZTS | TAK | ONC | UTHR |
| Company | Neurocrine Bioscienc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Beone Medicines Ltd | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 135.34 | 123.96 | 15.88 | 333.43 | 469.29 |
| High | 136.12 | 124.92 | 16.04 | 342.09 | 473.89 |
| Low | 133.72 | 123.68 | 15.78 | 332.90 | 465.28 |
| Latest | 135.48 | 124.90 | 16.01 | 341.50 | 469.06 |
| Change | +0.94 | +1.66 | -0.14 | +7.22 | +0.99 |
| % Change | +0.70% | +1.35% | -0.87% | +2.16% | +0.21% |
| Volume | 106,927 | 659,024 | 1,361,547 | 35,469 | 50,338 |
| 20-Day Average Volume | 1,001,159 | 4,139,502 | 2,426,191 | 278,584 | 338,293 |
| Previous Close | 134.54 | 123.24 | 16.15 | 334.28 | 468.07 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 138.74 | 125.75 | 15.89 | 324.77 | 490.51 |
| 20-Day Raw Stochastic | 30.11% | 33.27% | 70.25% | 75.22% | 23.73% |
| 20-Day Relative Strength | 42.13 | 47.46 | 61.42 | 55.36 | 44.84 |
| Weighted Alpha | -4.01 | -27.48 | +22.50 | +50.44 | +26.34 |
| Today's Opinion | 8% Sell | 56% Sell | 88% Buy | 72% Buy | 56% Buy |
| Previous Opinion | 8% Sell | 56% Sell | 88% Buy | 72% Buy | 56% Buy |
| Last Month's Opinion | 56% Buy | 88% Sell | 8% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.08% since 01/13/26 | -0.14% since 01/13/26 | -0.09% since 01/13/26 | -3.02% since 01/13/26 | -1.25% since 01/13/26 |
| Low | 129.17 on 01/20/26 | 121.65 on 01/20/26 | 15.79 on 01/21/26 | 325.10 on 01/20/26 | 455.63 on 01/20/26 |
| High | 135.98 on 01/15/26 | 126.50 on 01/14/26 | 16.48 on 01/14/26 | 353.10 on 01/14/26 | 481.29 on 01/14/26 |
| 1-Month | |||||
| %Chg | -6.89% since 12/19/25 | +1.81% since 12/19/25 | +7.35% since 12/19/25 | +7.73% since 12/19/25 | -8.94% since 12/19/25 |
| Low | 129.17 on 01/20/26 | 121.12 on 12/22/25 | 14.85 on 12/22/25 | 302.14 on 12/30/25 | 455.63 on 01/20/26 |
| High | 148.56 on 12/23/25 | 131.13 on 01/06/26 | 16.48 on 01/14/26 | 353.10 on 01/14/26 | 519.99 on 12/23/25 |
| 3-Month | |||||
| %Chg | -5.36% since 10/21/25 | -14.81% since 10/21/25 | +13.36% since 10/21/25 | +7.83% since 10/21/25 | +11.45% since 10/21/25 |
| Low | 129.17 on 01/20/26 | 115.25 on 11/19/25 | 12.99 on 10/30/25 | 299.50 on 12/16/25 | 409.07 on 10/28/25 |
| High | 160.18 on 12/08/25 | 148.30 on 10/22/25 | 16.48 on 01/14/26 | 385.22 on 11/17/25 | 519.99 on 12/23/25 |
| 6-Month | |||||
| %Chg | +2.41% since 07/21/25 | -15.55% since 07/21/25 | +10.77% since 07/21/25 | +16.63% since 07/21/25 | +60.65% since 07/21/25 |
| Low | 123.67 on 08/08/25 | 115.25 on 11/19/25 | 12.99 on 10/30/25 | 280.11 on 08/08/25 | 272.12 on 07/31/25 |
| High | 160.18 on 12/08/25 | 160.48 on 08/20/25 | 16.48 on 01/14/26 | 385.22 on 11/17/25 | 519.99 on 12/23/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 13,414,445 | 54,311,004 | 51,388,912 | 36,658,148 | 20,153,686 |
| Shares Outstanding, K | 99,706 | 440,693 | 3,181,976 | 109,663 | 43,057 |
| Annual Sales | 2,355,300,000 | 9,256,000,000 | 30,238,240,000 | 3,810,240,000 | 2,877,400,000 |
| Annual Net Income | 341,300,000 | 2,486,000,000 | 712,320,000 | -644,790,000 | 1,195,100,000 |
| Last Quarter Sales | 794,900,000 | 2,400,000,000 | 7,718,640,000 | 1,412,280,000 | 799,500,000 |
| Last Quarter Net Income | 209,500,000 | 721,000,000 | -81,860,000 | 124,840,000 | 338,700,000 |
| 60-Month Beta | 0.28 | 0.97 | 0.03 | 0.47 | 0.84 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.04 on 10/28/25 | 1.70 on 11/04/25 | 0.44 on 10/30/25 | 1.09 on 11/06/25 | 7.16 on 10/29/25 |
| Latest Earnings Date | 02/05/26 | 02/12/26 | 01/29/26 | 02/26/26 | 02/25/26 |
| Most Recent Dividend | N/A | 0.530 on 01/20/26 | 0.252 on 09/30/25 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 01/20/26 | 09/30/25 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 31.67 | 19.66 | 10.49 | 196.62 | 17.62 |